News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
714,598 Results
Type
Article (42327)
Company Profile (436)
Press Release (671835)
Multimedia
Podcasts (78)
Webinars (13)
Section
Business (208749)
Career Advice (2021)
Deals (36008)
Drug Delivery (104)
Drug Development (83582)
Employer Resources (173)
FDA (16433)
Job Trends (15098)
News (352812)
Policy (33084)
Tag
2025 BioForest Digital (4)
2025 Lone Star Bio Digital (8)
Academia (2643)
Accelerated approval (6)
Adcomms (24)
Allergies (87)
Alliances (50961)
ALS (94)
Alzheimer's disease (1430)
Antibody-drug conjugate (ADC) (139)
Approvals (16424)
Artificial intelligence (268)
Autoimmune disease (25)
Automation (16)
Bankruptcy (372)
Best Places to Work (11841)
BIOSECURE Act (19)
Biosimilars (106)
Biotechnology (330)
Bladder cancer (82)
Brain cancer (27)
Breast cancer (287)
Cancer (2316)
Cardiovascular disease (185)
Career advice (1689)
Career pathing (30)
CAR-T (157)
Cell therapy (444)
Cervical cancer (19)
Clinical research (67780)
Collaboration (877)
Compensation (532)
Complete response letters (24)
COVID-19 (2648)
CRISPR (45)
C-suite (252)
Cystic fibrosis (105)
Data (2232)
Decentralized trials (2)
Denatured (28)
Depression (50)
Diabetes (275)
Diagnostics (6427)
Digital health (19)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (127)
Drug pricing (107)
Drug shortages (26)
Duchenne muscular dystrophy (100)
Earnings (87833)
Editorial (40)
Employer branding (21)
Employer resources (147)
Events (115944)
Executive appointments (743)
FDA (17701)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (783)
Gene editing (113)
Generative AI (20)
Gene therapy (328)
GLP-1 (747)
Government (4503)
Grass and pollen (4)
Guidances (59)
Healthcare (19146)
Huntington's disease (24)
IgA nephropathy (30)
Immunology and inflammation (130)
Indications (30)
Infectious disease (2793)
Inflammatory bowel disease (143)
Inflation Reduction Act (11)
Influenza (52)
Intellectual property (98)
Interviews (311)
IPO (16789)
IRA (43)
Job creations (3701)
Job search strategy (1434)
Kidney cancer (10)
Labor market (38)
Layoffs (496)
Leadership (18)
Legal (7986)
Liver cancer (76)
Lung cancer (328)
Lymphoma (155)
Machine learning (7)
Management (58)
Manufacturing (313)
MASH (69)
Medical device (13526)
Medtech (13531)
Mergers & acquisitions (19758)
Metabolic disorders (718)
Multiple sclerosis (82)
NASH (19)
Neurodegenerative disease (102)
Neuropsychiatric disorders (33)
Neuroscience (2001)
NextGen: Class of 2025 (6755)
Non-profit (4550)
Now hiring (39)
Obesity (385)
Opinion (223)
Ovarian cancer (77)
Pain (89)
Pancreatic cancer (84)
Parkinson's disease (155)
Partnered (21)
Patents (236)
Patient recruitment (111)
Peanut (47)
People (58681)
Pharmaceutical (86)
Pharmacy benefit managers (19)
Phase I (21298)
Phase II (29908)
Phase III (22114)
Pipeline (1209)
Policy (146)
Postmarket research (2601)
Preclinical (9138)
Press Release (67)
Prostate cancer (110)
Psychedelics (37)
Radiopharmaceuticals (263)
Rare diseases (404)
Real estate (6015)
Recruiting (66)
Regulatory (22739)
Reports (46)
Research institute (2416)
Resumes & cover letters (351)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (76)
Series A (139)
Series B (90)
Service/supplier (11)
Sickle cell disease (57)
Special edition (17)
Spinal muscular atrophy (152)
Sponsored (30)
Startups (3762)
State (2)
Stomach cancer (14)
Supply chain (69)
Tariffs (39)
The Weekly (48)
Vaccines (705)
Venture capitalists (43)
Weight loss (255)
Women's health (37)
Worklife (17)
Date
Today (164)
Last 7 days (867)
Last 30 days (2688)
Last 365 days (33863)
2025 (10881)
2024 (36301)
2023 (41015)
2022 (52276)
2021 (56763)
2020 (54920)
2019 (47416)
2018 (35696)
2017 (33024)
2016 (32346)
2015 (38396)
2014 (32185)
2013 (27109)
2012 (29220)
2011 (29863)
2010 (27992)
Location
Africa (736)
Alabama (58)
Alaska (7)
Arizona (239)
Arkansas (14)
Asia (39257)
Australia (6532)
California (6238)
Canada (2022)
China (533)
Colorado (272)
Connecticut (285)
Delaware (149)
Europe (85801)
Florida (910)
Georgia (206)
Idaho (57)
Illinois (551)
India (25)
Indiana (310)
Iowa (12)
Japan (163)
Kansas (107)
Kentucky (24)
Louisiana (11)
Maine (62)
Maryland (907)
Massachusetts (4739)
Michigan (221)
Minnesota (396)
Mississippi (2)
Missouri (82)
Montana (29)
Nebraska (25)
Nevada (63)
New Hampshire (67)
New Jersey (1756)
New Mexico (30)
New York (1759)
North Carolina (1032)
North Dakota (8)
Northern California (2699)
Ohio (206)
Oklahoma (14)
Oregon (38)
Pennsylvania (1389)
Puerto Rico (12)
Rhode Island (34)
South America (1110)
South Carolina (22)
South Dakota (1)
Southern California (2328)
Tennessee (101)
Texas (923)
United States (23622)
Utah (183)
Virginia (149)
Washington D.C. (63)
Washington State (573)
West Virginia (3)
Wisconsin (54)
714,598 Results for "xortx therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
XORTX Announces Grant of European Patent
April 28, 2025
·
8 min read
Press Releases
XORTX Provides Update on FDA Type B Meeting Request
April 30, 2025
·
8 min read
Press Releases
XORTX Announces Update for Discussion with the FDA
March 19, 2025
·
8 min read
Press Releases
XORTX to Present at Microcap Conference
January 29, 2025
·
3 min read
Press Releases
XORTX Commences Gout Program NDA Discussions with the FDA
February 25, 2025
·
7 min read
Press Releases
XORTX Announces Change of Auditor
January 17, 2025
·
2 min read
XORTX to Present at BIO International Convention 2024
XORTX Therapeutics Inc. is pleased to announce its participation in the BIO International Convention 2024, being held June 3rd through 6th , 2024.
June 4, 2024
·
3 min read
Press Releases
XORTX Strengthens Executive Team
December 19, 2024
·
3 min read
Press Releases
XORTX Adds Late Stage Gout Program to Pipeline
January 6, 2025
·
5 min read
XORTX Announces Participation in Spring 2024 Investor Conferences
XORTX Therapeutics Inc. announces that Dr. Allen Davidoff, CEO, is scheduled to participate in the following Spring 2024 investor and life sciences investment conferences.
April 8, 2024
·
2 min read
1 of 71,460
Next
